Document ID: chunk:federal_register_of_legislation:F2025L00212:clause:1_1103
Version: federal_register_of_legislation:F2025L00212
Segment Type: clause
Provision Reference: sch 1 cl 1103
Character Range: 536875–537912

1103                                      CALCIUM PROPIONATE                                                                               E         Only to be used in a medicine where Procter & Gamble Australia Pty Ltd (Client ID 11364), who applied to have the ingredient included in this Determination, is the sponsor of the medicine or has given written authorisation to the sponsor of a medicine to include the ingredient in the medicine. This paragraph ceases to be a requirement for this ingredient after 1 March 2027.
                                                                                                                                                     The route of administration for medicines that contain calcium propionate must be limited to oral.
                                                                                                                                                     The maximum recommended daily dose of the medicine must not provide more than 1 milligram of calcium propionate.